The reiteration of a Buy rating and a maintained price target of $5 by a reputable analyst firm like HC Wainwright & Co. is likely to instill confidence among investors and could lead to a positive short-term impact on the stock price of Oncolytics Biotech. Analyst ratings, especially those that are positive, tend to influence market perception and investor sentiment, potentially driving up the stock price in the short term.